Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Mohamed T. El-Saadony, Nidal M. Zabermawi, Nehal M. Zabermawi, Maryam A. Burollus, Manal E. Shafi, Mahmoud Alagawany, Nahed Yehia, Ahmed M. Askar, Sara A. Alsafy, Ahmed E. Noreldin, Asmaa F. Khafaga, Kuldeep Dhama, Shaaban S. Elnesr, Hamada A. M. Elwan, Alessandro Di Cerbo, Khaled A. El-Tarabily & Mohamed E. Abd El-Hack. (2023) Nutritional Aspects and Health Benefits of Bioactive Plant Compounds against Infectious Diseases: A Review. Food Reviews International 39:4, pages 2138-2160.
Read now
Read now
Tomasz Ginda, Karol Taradaj & Bożena Kociszewska-Najman. (2022) The influence of selected factors on the immunogenicity of preventive vaccinations against hepatitis A, B and influenza in solid organ transplant recipients undergoing immunosuppressive therapy – a review. Expert Review of Vaccines 21:4, pages 483-497.
Read now
Read now
Benjamas Chuaychoo, Uraiwan Kositanont, Parichat Niyomthong, Nuttapol Rittayamai, Sorachai Srisuma, Kanokwan Rattanasaengloet, Walaiporn Wongsrisakunkaew, Julalux Thongam & Thaweesak Songserm. (2020) Comparison of immunogenicity between intradermal and intramuscular injections of repeated annual identical influenza virus strains post-pandemic (2011-2012) in COPD patients. Human Vaccines & Immunotherapeutics 16:6, pages 1371-1379.
Read now
Read now
Antonino Bella, Francesco Gesualdo, Andrea Orsi, Claudia Arcuri, Maria Chironna, Daniela Loconsole, Christian Napoli, Giovanni Battista Orsi, Ilaria Manini, Emanuele Montomoli, Valeria Alfonsi, Maria Rita Castrucci & Caterina Rizzo. (2019) Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017 – 2018 season. Expert Review of Vaccines 18:6, pages 671-679.
Read now
Read now
Ivan F. N. Hung & Kwok-Yung Yuen. (2018) Immunogenicity, safety and tolerability of intradermal influenza vaccines. Human Vaccines & Immunotherapeutics 14:3, pages 565-570.
Read now
Read now
Emilia Nunzi, Anna Maria Iorio & Barbara Camilloni. (2017) A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60–85 years old) and very elderly (>85 years old) institutionalized subjects. Human Vaccines & Immunotherapeutics 13:11, pages 2659-2668.
Read now
Read now
Corwin A. Robertson, Carlos A. DiazGranados, Michael D. Decker, Ayman Chit, Monica Mercer & David P. Greenberg. (2016) Fluzone® High-Dose Influenza Vaccine. Expert Review of Vaccines 15:12, pages 1495-1505.
Read now
Read now
Nicola Luigi Bragazzi, Andrea Orsi, Filippo Ansaldi, Roberto Gasparini & Giancarlo Icardi. (2016) Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview. Human Vaccines & Immunotherapeutics 12:10, pages 2616-2627.
Read now
Read now
Corwin A. Robertson, Peter Tsang, Victoria A. Landolfi & David P. Greenberg. (2016) Fluzone® Intradermal Quadrivalent Influenza Vaccine. Expert Review of Vaccines 15:10, pages 1245-1253.
Read now
Read now
Articles from other publishers (40)
Shintaro Shichinohe & Tokiko Watanabe. (2023) Advances in Adjuvanted Influenza Vaccines. Vaccines 11:8, pages 1391.
Crossref
Crossref
Michele A. Kohli, Michael Maschio, Shannon Cartier, Joaquin Mould-Quevedo & Frank-Ulrich Fricke. (2022) The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany. Vaccines 10:9, pages 1386.
Crossref
Crossref
Matthew R. Bell & Michele A. Kutzler. (2022) An old problem with new solutions: Strategies to improve vaccine efficacy in the elderly. Advanced Drug Delivery Reviews 183, pages 114175.
Crossref
Crossref
Birgit Weinberger. 2022. Healthy Longevity and Immune System. Healthy Longevity and Immune System
119
164
.
Birgit Weinberger. (2021) Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond. Immunity & Ageing 18:1.
Crossref
Crossref
Tanja Becker, Husni Elbahesh, Leslie A Reperant, Guus F Rimmelzwaan & Albert D M E Osterhaus. (2021) Influenza Vaccines: Successes and Continuing Challenges. The Journal of Infectious Diseases 224:Supplement_4, pages S405-S419.
Crossref
Crossref
Toshiki Sekiya, Marumi Ohno, Naoki Nomura, Chimuka Handabile, Masashi Shingai, David C. Jackson, Lorena E. Brown & Hiroshi Kida. (2021) Selecting and Using the Appropriate Influenza Vaccine for Each Individual. Viruses 13:6, pages 971.
Crossref
Crossref
Jiangan Xie, Wenrui Zi, Zhangyong Li & Yongqun He. (2021) Ontology-based Precision Vaccinology for Deep Mechanism Understanding and Precision Vaccine Development. Current Pharmaceutical Design 27:7, pages 900-910.
Crossref
Crossref
Marco Mandolesi, Daniel J. Sheward, Leo Hanke, Junjie Ma, Pradeepa Pushparaj, Laura Perez Vidakovics, Changil Kim, Monika Àdori, Klara Lenart, Karin Loré, Xaquin Castro Dopico, Jonathan M. Coquet, Gerald M. McInerney, Gunilla B. Karlsson Hedestam & Ben Murrell. (2021) SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses. Cell Reports Medicine 2:4, pages 100252.
Crossref
Crossref
Anthony L Cunningham, Peter McIntyre, Kanta Subbarao, Robert Booy & Myron J Levin. (2021) Vaccines for older adults. BMJ, pages n188.
Crossref
Crossref
Ozlem Bulut, Gizem Kilic, Jorge Domínguez-Andrés & Mihai G Netea. (2020) Overcoming immune dysfunction in the elderly: trained immunity as a novel approach. International Immunology 32:12, pages 741-753.
Crossref
Crossref
Benjamin J Cowling, Ranawaka A P M Perera, Sophie A Valkenburg, Nancy H L Leung, A Danielle Iuliano, Yat Hung Tam, Jennifer H F Wong, Vicky J Fang, Athena P Y Li, Hau Chi So, Dennis K M Ip, Eduardo Azziz-Baumgartner, Alicia M Fry, Min Z Levine, Shivaprakash Gangappa, Suryaprakash Sambhara, Ian G Barr, Danuta M Skowronski, J S Malik Peiris & Mark G Thompson. (2020) Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial. Clinical Infectious Diseases 71:7, pages 1704-1714.
Crossref
Crossref
Benjamin J Cowling, Mark G Thompson, Tiffany W Y Ng, Vicky J Fang, Ranawaka A P M Perera, Nancy H L Leung, Yuyun Chen, Hau Chi So, Dennis K M Ip & A Danielle Iuliano. (2020) Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults. The Journal of Infectious Diseases 222:8, pages 1383-1391.
Crossref
Crossref
Angelika Wagner & Birgit Weinberger. (2020) Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives. Frontiers in Immunology 11.
Crossref
Crossref
Chih-Jen Wei, Michelle C. Crank, John Shiver, Barney S. Graham, John R. Mascola & Gary J. Nabel. (2020) Next-generation influenza vaccines: opportunities and challenges. Nature Reviews Drug Discovery 19:4, pages 239-252.
Crossref
Crossref
Pureum Lee & Doo-Jin Kim. (2020) Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19. Immune Network 20:4.
Crossref
Crossref
Elena Gonçalves & Béhazine Combadière. (2020) Prédire la réponse à la vaccination contre la grippe. médecine/sciences 36:1, pages 31-37.
Crossref
Crossref
Brandon Essink, Carlos Fierro, Jeffrey Rosen, Amparo L. Figueroa, Bin Zhang, Carole Verhoeven, Jonathan Edelman & Igor Smolenov. (2020) Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults. Vaccine 38:2, pages 242-250.
Crossref
Crossref
B. Autran. (2019) Altération des réponses vaccinales avec l’âge. Revue des Maladies Respiratoires 36:9, pages 1047-1056.
Crossref
Crossref
Nobuo Hirotsu, Yutaka Saisho, Takahiro Hasegawa, Mitsutaka Kitano & Takao Shishido. (2019) Antibody dynamics in Japanese paediatric patients with influenza A infection treated with neuraminidase inhibitors in a randomised trial. Scientific Reports 9:1.
Crossref
Crossref
Sanjay S. Patel, Svetlana Bizjajeva, Esther Heijnen & Janine Oberye. (2019) MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: Safety and immunogenicity in young children at risk of influenza complications. International Journal of Infectious Diseases 85, pages S18-S25.
Crossref
Crossref
Eléna Gonçalves, Olivia Bonduelle, Angèle Soria, Pierre Loulergue, Alexandra Rousseau, Marine Cachanado, Henri Bonnabau, Rodolphe Thiebaut, Nicolas Tchitchek, Sylvie Behillil, Sylvie van der Werf, Annika Vogt, Tabassome Simon, Odile Launay & Behazine Combadière. (2019) Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination. Journal of Clinical Investigation 129:5, pages 1960-1971.
Crossref
Crossref
Ivo Vojtek, Philippe Buchy, T. Mark Doherty & Bernard Hoet. (2019) Would immunization be the same without cross-reactivity?. Vaccine 37:4, pages 539-549.
Crossref
Crossref
Melissa K. Andrew, Susan K. Bowles, Graham Pawelec, Laura Haynes, George A. Kuchel, Shelly A. McNeil & Janet E. McElhaney. (2018) Influenza Vaccination in Older Adults: Recent Innovations and Practical Applications. Drugs & Aging 36:1, pages 29-37.
Crossref
Crossref
Axel Rossi & Hildegard Büning. 2019. Muscle Gene Therapy. Muscle Gene Therapy
645
659
.
Nikunj M. Shukla, Kei-Ichiro Arimoto, Shiyin Yao, Jun-Bao Fan, Yue Zhang, Fumi Sato-Kaneko, Fitzgerald S. Lao, Tadashi Hosoya, Karen Messer, Minya Pu, Howard B. Cottam, Dennis A. Carson, Tomoko Hayashi, Dong-Er Zhang & Maripat Corr. (2018) Identification of Compounds That Prolong Type I Interferon Signaling as Potential Vaccine Adjuvants. SLAS Discovery 23:9, pages 960-973.
Crossref
Crossref
G.A. Poland, I.G. Ovsyannikova & R.B. Kennedy. (2018) Personalized vaccinology: A review. Vaccine 36:36, pages 5350-5357.
Crossref
Crossref
Birgit Weinberger. (2018) Adjuvant strategies to improve vaccination of the elderly population. Current Opinion in Pharmacology 41, pages 34-41.
Crossref
Crossref
William Schaffner, Wilbur H. Chen, Robert H. Hopkins & Kathleen Neuzil. (2018) Effective Immunization of Older Adults Against Seasonal Influenza. The American Journal of Medicine 131:8, pages 865-873.
Crossref
Crossref
A. Kwetkat, A. Leischker & H. J. Heppner. (2018) Influenza: besondere Aspekte im höheren LebensalterInfluenza: special aspects in old age. Zeitschrift für Gerontologie und Geriatrie 51:5, pages 585-596.
Crossref
Crossref
Jin Seo Lee. (2018) Treatment and prophylaxis of influenza. Journal of the Korean Medical Association 61:1, pages 49.
Crossref
Crossref
Marc Rondy, Nathalie El Omeiri, Mark G. Thompson, Alain Levêque, Alain Moren & Sheena G. Sullivan. (2017) Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies. Journal of Infection 75:5, pages 381-394.
Crossref
Crossref
Peter H. Goff, Tomoko Hayashi, Wenqian He, Shiyin Yao, Howard B. Cottam, Gene S. Tan, Brian Crain, Florian Krammer, Karen Messer, Minya Pu, Dennis A. Carson, Peter Palese & Maripat Corr. (2017) Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice. Journal of Virology 91:19.
Crossref
Crossref
Michael Chan, Alast Ahmadi, Shiyin Yao, Fumi Sato-Kaneko, Karen Messer, Minya Pu, Brandon Nguyen, Tomoko Hayashi, Maripat Corr, Dennis A. Carson, Howard B. Cottam & Nikunj M. Shukla. (2017)
Identification of Biologically Active Pyrimido[5,4-
b
]indoles That Prolong NF-κB Activation without Intrinsic Activity
. ACS Combinatorial Science 19:8, pages 533-543.
Crossref
Crossref
David Goldeck, Heidi Theeten, Fakhri Hassouneh, Lilly Oettinger, Kilian Wistuba-Hamprecht, Nathalie Cools, Ourania E. Tsitsilonis & Graham Pawelec. (2017) Frequencies of peripheral immune cells in older adults following seasonal influenza vaccination with an adjuvanted vaccine. Vaccine 35:34, pages 4330-4338.
Crossref
Crossref
Catharine Paules & Kanta Subbarao. (2017) Influenza. The Lancet 390:10095, pages 697-708.
Crossref
Crossref
Alexander Domnich, Lucia Arata, Daniela Amicizia, Joan Puig-Barberà, Roberto Gasparini & Donatella Panatto. (2017) Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis. Vaccine 35:4, pages 513-520.
Crossref
Crossref
Momoko Kitaoka, Rie Wakabayashi, Noriho Kamiya & Masahiro Goto. (2016) Solid‐in‐oil nanodispersions for transdermal drug delivery systems. Biotechnology Journal 11:11, pages 1375-1385.
Crossref
Crossref
Alice Gutjahr, Gérard Tiraby, Eric Perouzel, Bernard Verrier & Stéphane Paul. (2016) Triggering Intracellular Receptors for Vaccine Adjuvantation. Trends in Immunology 37:9, pages 573-587.
Crossref
Crossref
Michelle Steeper, Magdalena Plebanski & Katie L Flanagan. (2016) The global challenge and future strategies for keeping the world's aging population healthy by vaccination. Transactions of The Royal Society of Tropical Medicine and Hygiene 110:8, pages 427-431.
Crossref
Crossref